SOMNF (SomnoMed) Dividends Received: $0.00 Mil (TTM As of Dec. 2025)


SOMNF SomnoMed Ltd SOMNF
53 GF Score
Price $0.45
GF Value $0.40
! 3 Warning Signs
View Full Analysis

What is SomnoMed Dividends Received?

SomnoMed SOMNF 53 Dividends Received is $0.00 Mil as of Dec. 2025. GuruFocus rates SOMNF with a GF Score™ of 53/100 and a GF Value™ of $0.40. The stock has 3 warning signs investors should review.

SomnoMed's Dividends Received for the six months ended in Dec. 2025 was $0.00 Mil.

SomnoMed's Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

SomnoMed Dividends Received Related Terms

SomnoMed Dividends Received Historical Data

* Premium members only.

The historical data trend for SomnoMed's Dividends Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Dividends Received Chart

SomnoMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividends Received
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SomnoMed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends Received Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SOMNF
53GF Score
SomnoMed Ltd SOMNF
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SomnoMed Dividends Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Received represents dividend received on the investment in the direct cash flow method.

Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Received →
What does a Dividends Received of $0.00 Mil mean?
SomnoMed (SOMNF) has a Dividends Received of $0.00 Mil as of Dec. 2025. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for SomnoMed and its competitors.
Is SomnoMed's Dividends Received too high?
SomnoMed's current Dividends Received is $0.00 Mil. Overall, SomnoMed has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Dividends Received compare to ABT and SYK?
SomnoMed's Dividends Received of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Received for a Medical Devices & Instruments company?
A good Dividends Received depends on the Medical Devices & Instruments industry context. However, Dividends Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Received mean?
A high Dividends Received can signal that a stock is expensive relative to its fundamentals. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for SomnoMed and its competitors. SomnoMed's current Dividends Received is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
SomnoMed (SOMNF) has a current Dividends Received of $0.00 Mil. The stock's GF Value™ is $0.40, compared to a current price of $0.45 — trading 12% above its estimated fair value. The current Dividends Received is $0.00 Mil. SomnoMed's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Received calculated?
Dividends Received is calculated from a company's financial statements. For SomnoMed (SOMNF), the current Dividends Received is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SomnoMed (SOMNF) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued. The current stock price of $0.45 is trading 12% above its estimated GF Value™ of $0.40.

Key valuation signals for SOMNF:

  • Dividends Received: $0.00 Mil
  • GF Value™: $0.40 vs. price of $0.45 (12% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the SOMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges RJV:GermanySOM:Australia
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
53GF Score

Get the complete analysis for SOMNF

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.45
Price
$0.40
GF Value